A Brighter Future — ABF Wellness ShopABF Wellness ShopWellness Shop
Research LibraryPeptide Research

Ipamorelin

Investigational Peptide

An investigational growth hormone secretagogue with limited human trials; not FDA-approved for any indication.

Limited human evidenceLast reviewed October 27, 2026

Ipamorelin is a synthetic peptide that acts as a growth hormone secretagogue by stimulating the ghrelin receptor, also called GHS-R1a. It was developed to investigate whether growth hormone release could be stimulated selectively through this receptor. Ipamorelin has been explored in endocrine research and in studies of gastrointestinal motility.

Medical information disclaimer

This page is educational only and is not medical advice. It does not describe an approved treatment for every individual and does not guarantee that any product is available for purchase. Investigational compounds are not offered for sale or treatment booking through this storefront. FDA approval applies to specific drug products and indications, not automatically to every formulation containing the same ingredient.

References & Further Reading

  • Randomized clinical trial of ipamorelin for postoperative ileus — PubMed / National Library of Medicinesource
  • FDA bulk-substance safety assessment for ipamorelin acetate — U.S. Food and Drug Administrationsource

This entry was last reviewed on October 27, 2026 and requires clinical review before publication. ABF's medical and legal advisers may revise research findings and regulatory information as evidence changes.

Related Research

Sermorelin

Clinical/Regulatory Review Required

BPC-157

Investigational Peptide

TB-500

Investigational Peptide